Some experts argue that we should think of ADHD as a spectrum of behaviors rather than a condition you either have or don't ...

A recent study suggested that more than 15 million U.S. adults — roughly 1 in 17 — have been diagnosed with ADHD. The ...

Adderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder to other forms of ...

The life expectancy of adults with attention-deficit and hyperactivity disorder (ADHD) is significantly shorter than that of ...

On average, women diagnosed with attention-deficit/hyperactivity disorder died almost nine years earlier, while men died ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...

The following is a summary of “Pediatric Attention-Deficit/Hypearativity Disorder and Disruptive Mood Dysregulation Disorder: ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

Having attention deficit hyperactivity disorder is associated with a shorter life expectancy and a greater risk of mental ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...